After receiving his doctor of medicine in neuroscience in 1994 from the University of Birmingham, Sanjiv Narayan Abbott went on to a career in medicine with a focus on research and education. Currently a professor of medicine at Stanford, Sanjiv Narayan Abbott works in the San Francisco Bay area and treats Atrial Fibrillation.
Atrial fibrillation (AF), the most common form of arrhythmia, is characterized by an erratic heartbeat that is often too fast. It can increase the risk of stroke and heart failure. Despite data proving that blood thinners are superior to treating the condition, research published in the Journal of the American College of Cardiology indicates that about 40% of AF patients at intermediate to high risk for stroke are treated with only aspirin.
Earlier studies have shown that warfarin (oral blood thinner) reduced thromboembolism (blood clot obstructing blood vessel) better than aspirin. According to Jonathan C. Hsu, MD, cardiologist at UC San Diego Health, aspirin alone is not very effective in stroke prevention, and the risk of intracranial hemorrhage remains.